Foresee Pharmaceuticals Co., Ltd.

ACTIVE

9F-2, No. 19-3, Sanchong Rd., 台湾 Taipei, 台湾省, Taiwanwww.foreseepharma.comPublic51–100 employeesEstablished: 2013-01-01

Clinical Trials

13 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2013

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

56.3%

Phase 2

18.8%

Phase 3

18.8%

Phase 2/3

3.1%

Trial Status Distribution

Active, not recruiting

31.3%

Completed

43.8%

Not yet recruiting

9.4%

Recruiting

3.1%

Terminated

3.1%

Withdrawn

9.4%

Clinical Trials

Trials sponsored by this organization (32)

Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)

Phase 2

Not yet recruiting

interventional

Mar 2027135 participants

Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer

Phase 3

Withdrawn

interventional

Jul 2025148 participants

Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer

Phase 3

Withdrawn

interventional

Jun 2025148 participants

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)

Phase 2

Recruiting

interventional

Mar 2025126 participants

Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Ascending Doses of FP-020 in Healthy Adult Volunteers

Phase 1

Completed

interventional

Apr 202464 participants

A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia

Phase 1

Withdrawn

interventional

Jun 202316 participants

Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Phase 3

Completed

interventional

Jun 202394 participants

Open-Label, Randomized, Fasted, Single Oral Dose, Crossover Trial to Assess the Relative Bioavailability of FP-045 and its Metabolite AD-835 After Single Doses of FP-045 2 X 75 mg Capsules (Test Drug) Compared to 150 mg Reconstituted FP-045 Drug Substance Liquid Formulation (Reference Drug) in Healthy Male Participants

Phase 1

Completed

interventional

Feb 20238 participants

Page 1 of 4

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations